Infliximab-Abda
Composition
Infliximab-Abda is a monoclonal antibody that binds to tumor necrosis factor alpha (TNF-α).
Indications
Used to treat various autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
Side effects
Common side effects include respiratory infections, headache, nausea, abdominal pain, and infusion reactions.
Precautions
Caution should be taken in patients with heart failure.
Contraindications
Contraindicated in patients with heart failure.
Dosage and administration
Administered by intravenous infusion.
Countries
Worldwide
Available Forms
Dried powder for IV infusion
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai